Cargando…

Added Value of Ultrasound-Based Multimodal Imaging to Diagnose Hepatic Sclerosed Hemangioma before Biopsy and Resection

Imaging methods have the overwhelming advantage of being non-invasive in the diagnosis of hepatic lesions and, thanks to technical developments in the field of ultrasound (US), radiation exposure can also be avoided in many clinical situations. In particular, contrast-enhanced US (CEUS) outperforms...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Feiqian, Numata, Kazushi, Nihonmatsu, Hiromi, Chuma, Makoto, Ideno, Naomi, Nozaki, Akito, Ogushi, Katsuaki, Tanab, Mikiko, Okada, Masahiro, Luo, Wen, Nakano, Masayuki, Otani, Masako, Inayama, Yoshiaki, Maeda, Shin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689571/ https://www.ncbi.nlm.nih.gov/pubmed/36428878 http://dx.doi.org/10.3390/diagnostics12112818

Ejemplares similares

Diagnostic Value of Imaging Methods in the Histological Four Grading of Hepatocellular Carcinoma
por: Wang, Feiqian, et al.
Publicado: (2020)

Optimal application of stereotactic body radiotherapy and radiofrequency ablation treatment for different multifocal hepatocellular carcinoma lesions in patients with Barcelona Clinic Liver Cancer stage A4–B1: a pilot study
por: Wang, Feiqian, et al.
Publicado: (2021)

Liver Injury and Use of Contrast-Enhanced Ultrasound for Evaluating Intrahepatic Recurrence in a Case of TACE-Refractory Hepatocellular Carcinoma Receiving Atezolizumab-Bevacizumab Combination Therapy: A Case Report
por: Komiyama, Satoshi, et al.
Publicado: (2021)

Combination Therapy With Lenvatinib and Radiofrequency Ablation for Patients With Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh Class A Liver function: A Pilot Study
por: Wang, Feiqian, et al.
Publicado: (2022)

Safety and efficacy study: Short-term application of radiofrequency ablation and stereotactic body radiotherapy for Barcelona Clinical Liver Cancer stage 0–B1 hepatocellular carcinoma
por: Wang, Feiqian, et al.
Publicado: (2021)

Therapeutic effects of regorafenib after sorafenib monotherapy with advanced hepatocellular carcinoma including Child–Pugh classification B: A retrospective observational study
por: Komiyama, Satoshi, et al.
Publicado: (2020)

Treatment of Advanced Hepatocellular Carcinoma after Failure of Sorafenib Treatment: Subsequent or Additional Treatment Interventions Contribute to Prolonged Survival Postprogression
por: Kondo, Masaaki, et al.
Publicado: (2017)

Comparison of vascularity observed using contrast-enhanced 3D ultrasonography and pathological changes in patients with hepatocellular carcinoma after sorafenib treatment
por: Fukuda, Hiroyuki, et al.
Publicado: (2018)

Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases
por: Tarao, Kazuo, et al.
Publicado: (2020)

Use of Contrast-Enhanced Ultrasound with Sonazoid for Evaluating the Radiotherapy Efficacy for Hepatocellular Carcinoma
por: Funaoka, Akihiro, et al.
Publicado: (2021)

Comparison of unenhanced magnetic resonance imaging and ultrasound in detecting very small hepatocellular carcinoma
por: Tarao, Kazuo, et al.
Publicado: (2021)

Preoperative diagnosis of the sclerosed hemangioma of the liver using multimodality imaging findings: A case report
por: Ozaki, Kumi, et al.
Publicado: (2018)

Sofosbuvir-based therapies associated with regression of liver fibrosis in patients with hepatitis C virus infection: A prospective observational study
por: Nozaki, Akito, et al.
Publicado: (2021)

Peritumoral Hyperplasia in Hepatic Sclerosed Hemangioma
por: Shimada, Seitarou, et al.
Publicado: (2017)

Hepatic sclerosed hemangioma and sclerosing cavernous hemangioma: a radiological study
por: Jia, Cuiyu, et al.
Publicado: (2021)

Sclerosing hemangioma in the liver
por: Shin, Yong Moon
Publicado: (2011)

Sclerosed hemangioma of the liver
por: Jin, So-Young
Publicado: (2010)

Usefulness of 3D slicer for the planning and monitoring of hepatocellular carcinoma treatment using FUS
por: Doba, Nobutaka, et al.
Publicado: (2015)

A sclerosing hemangioma of the liver
por: Song, Ji Soo, et al.
Publicado: (2013)

Sclerosed Hemangioma Accompanied by Multiple Cavernous Hemangiomas of the Liver
por: Yuki, Michiko, et al.
Publicado: (2015)

Bone metastasis in pulmonary sclerosing hemangioma
por: Kim, Min Kyoung, et al.
Publicado: (2015)

Pathological Appearance of Focal Liver Reactions after Radiotherapy for Hepatocellular Carcinoma
por: Okada, Masahiro, et al.
Publicado: (2022)

A hepatic sclerosing hemangioma emerged in the postoperative course of multiple gastric carcinoid tumors masquerading as metachronous liver metastasis
por: Koyama, Ryota, et al.
Publicado: (2019)

Hepatic Sclerosing Hemangioma with Predominance of the Sclerosed Area Mimicking a Biliary Cystadenocarcinoma
por: Sugo, Hiroyuki, et al.
Publicado: (2018)

Pulmonary sclerosing hemangioma: report of two cases
por: He, Chuang, et al.
Publicado: (2012)

Respiratory motion tracking system of hepatocellular carcinoma treatment using FUS
por: Fukuda, Hiroyuki, et al.
Publicado: (2015)

Rate of local tumor progression following radiofrequency ablation of pathologically early hepatocellular carcinoma
por: Hao, Yoshiteru, et al.
Publicado: (2017)

A Case of a Ruptured Sclerosing Liver Hemangioma
por: Papafragkakis, Haris, et al.
Publicado: (2011)

Treatment of 28 patients with sclerosing hemangioma (SH) of the lung
por: Lei, Yang, et al.
Publicado: (2012)

The significance of p40 expression in sclerosing hemangioma of lung
por: Wu, Jian, et al.
Publicado: (2014)

Preoperative Diagnosis in 46 Cases of Pulmonary Sclerosing Hemangioma
por: Hu, Ai-Min, et al.
Publicado: (2016)

Pulmonary Hilar Tumor: An Unusual Presentation of Sclerosing Hemangioma
por: Hung, Jui-Hung, et al.
Publicado: (2016)

Sixteen Cases of Sclerosing Hemangioma of the Lung Including Unusual Presentations
por: Kim, Gou Young, et al.
Publicado: (2004)

Surgery for Pulmonary Sclerosing Hemangioma: Lobectomy versus Limited Resection
por: Park, Joon Seok, et al.
Publicado: (2011)

Hepatic Sclerosed Hemangioma: a case report and review of the literature
por: Miyamoto, Shunsuke, et al.
Publicado: (2015)

Case report: Sclerosed hemangioma of the liver: A diagnostic challenge
por: Poras, M., et al.
Publicado: (2022)

Early Changes in Circulating FGF19 and Ang-2 Levels as Possible Predictive Biomarkers of Clinical Response to Lenvatinib Therapy in Hepatocellular Carcinoma
por: Chuma, Makoto, et al.
Publicado: (2020)

New developments in ablation therapy for hepatocellular carcinoma: combination with systemic therapy and radiotherapy
por: Numata, Kauzshi, et al.
Publicado: (2022)

Lenvatinib for large hepatocellular carcinomas with portal trunk invasion: Two case reports
por: Komiyama, Satoshi, et al.
Publicado: (2020)

Effectiveness of entecavir in preventing hepatocellular carcinoma development is genotype-dependent in hepatitis B virus-associated liver cirrhosis
por: Tarao, Kazuo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g6g2t9lgfb8b1nqlkoe5ukn5l0